Autism spectrum disorder and co-occurring substance use disorder - A systematic review

Substance Abuse: Research and Treatment

Volumn 10, Issue , 2016, Pages 69-75

  Arnevik, Espen Ajo ^a,b   Helverschou, Sissel Berge ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Autism spectrum disorder; Epidemiology; Review; Substance use disorder

Indexed keywords

AUTISM; AWARENESS; CLINICAL ASSESSMENT; CLINICAL PRACTICE; COMORBIDITY; COPING BEHAVIOR; DRUG DEPENDENCE; EVIDENCE BASED PRACTICE; GEOGRAPHIC DISTRIBUTION; HELP SEEKING BEHAVIOR; HUMAN; INCIDENCE; PRACTICE GUIDELINE; PREVALENCE; REVIEW; SEXUAL CRIME; SOCIAL STATUS; SOCIALIZATION; SYSTEMATIC REVIEW;

EID: 84986540266     PISSN: None     EISSN: 11782218     Source Type: Journal    
DOI: 10.4137/SART.S39921     Document Type: Review

References (36)

1. Brorson HH, Ajo Arnevik E, Rand-Hendriksen K, Duckert F. Drop-out from addiction treatment: a systematic review of risk factors. Clin Psychol Rev. 2013;33(8):1010-24.
2. WHO. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: WHO; 1993.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth ed. Arlington, VA: American Psychiatric Association; 2013.
4. Ryan RM. Treatment-resistant chronic mental illness: is it Asperger’s syndrome? Hosp Community Psychiatry. 1992;43(8):807-11.
5. Joshi G, Wozniak J, Petty C, et al. Psychiatric comorbidity and functioning in a clinically referred population of adults with autism spectrum disorders: a comparative study. J Autism Dev Disord. 2013;43(6):1314-25.
6. Helverschou SB, Bakken TL, Martinsen H. Psychiatric disorders in people with autism spectrum disorders: phenomenology and recognition. International Handbook of Autism and Pervasive Developmental Disorders. New York, NY: Springer Science + Business Media; 2011:53-74.
7. Jane-Llopis EVA, Matytsina I. Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug Alcohol Rev. 2006;25(6):515-36.
8. Palmquist E, Claeson AS, Neely G, Stenberg B, Nordin S. Overlap in prevalence between various types of environmental intolerance. Int J Hyg Environ Health. 2014;217(4-5):427-34.
9. Santosh PJ, Mijovic A. Does pervasive developmental disorder protect children and adolescents against drug and alcohol use? Eur Child Adolesc Psychiatry. 2006;15(4):183-8.
10. Hofvander B, Delorme R, Chaste P, et al. Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders. BMC Psychiatry. 2009;9:35.
11. Sizoo B, van den Brink W, Gorissen van Eenige M, van der Gaag RJ. Personality characteristics of adults with autism spectrum disorders or attention deficit hyperactivity disorder with and without substance use disorders. J Nerv Ment Dis. 2009;197(6):450-4.
12. Sizoo B, van den Brink W, Koeter M, Gorissen van Eenige M, van Wijngaarden-Cremers P, van der Gaag RJ. Treatment seeking adults with autism or ADHD and co-morbid substance use disorder: prevalence, risk factors and functional disability. Drug Alcohol Depend. 2010;107(1):44-50.
13. Abdallah MW, Greaves-Lord K, Grove J, Norgaard-Pedersen B, Hougaard DM, Mortensen EL. Psychiatric comorbidities in autism spectrum disorders: findings from a Danish Historic Birth Cohort. Eur Child Adolesc Psychiatry. 2011;20(11-2): 599-601.
14. Lugnegård T, Hallerback MU, Gillberg C. Psychiatric comorbidity in young adults with a clinical diagnosis of Asperger syndrome. Res Dev Disabil. 2011;32(5):1910-7.
15. Lundström S, Chang Z, Kerekes N, et al. Autistic-like traits and their association with mental health problems in two nationwide twin cohorts of children and adults. Psychol Med. 2011;41(11):2423-33.
16. Mandell DS, Lawer LJ, Branch K, et al. Prevalence and correlates of autism in a state psychiatric hospital. Autism. 2012;16(6):557-67.
17. Søndenaa E, Helverschou SB, Steindal K, Rasmussen K, Nilson B, Nottestad JA. Violence and sexual offending behavior in people with autism spectrum disorder who have undergone a psychiatric forensic examination. Psychol Rep. 2014;115(1):32-43.
18. Helverschou SB, Rasmussen K, Steindal K, Søndanaa E, Nilsson B, Nøttestad JA. Offending profiles of individuals with ASD; a study of all individuals with ASD examined by the expert forensic psychiatric service in Norway between 2000 and 2010. Autism. 2015;19(7):850-8.
19. Ståhlberg O, Anckarsater H, Nilsson T. Mental health problems in youths committed to juvenile institutions: prevalences and treatment needs. Eur Child Adolesc Psychiatry. 2010;19(12):893-903.
20. Ramos M, Boada L, Moreno C, Llorente C, Romo J, Parellada M. Attitude and risk of substance use in adolescents diagnosed with Asperger syndrome. Drug Alcohol Depend. 2013;133(2):535-40.
21. Kronenberg LM, Slager-Visscher K, Goossens PJ, van den Brink W, van Achterberg T. Everyday life consequences of substance use in adult patients with a substance use disorder (SUD) and co-occurring attention deficit/ hyperactivity disorder (ADHD) or autism spectrum disorder (ASD): a patient’s perspective. BMC Psychiatry. 2014;14:264.
22. Kronenberg LM, Goossens PJ, van Etten DM, van Achterberg T, van den Brink W. Need for care and life satisfaction in adult substance use disorder patients with and without attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). Perspect Psychiatr Care. 2015;51(1):4-15.
23. Lalanne L, Weiner L, Trojak B, Berna F, Bertschy G. Substance-use disorder in high-functioning autism: clinical and neurocognitive insights from two case reports. BMC Psychiatry. 2015;15:149.
24. Kronenberg LM, Goossens PJ, van Busschbach J, van Achterberg T, van den Brink W. Coping styles in substance use disorder (SUD) patients with and without co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). BMC Psychiatry. 2015;15:159.
25. Kronenberg LM, Verkerk-Tamminga R, Goossens PJ, van den Brink W, van Achterberg T. Personal recovery in individuals diagnosed with substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). Arch Psychiatr Nurs. 2015;29(4): 242-8.
26. Howlin P, Moss P. Adults with autism spectrum disorders. Can J Psychiatry. 2012;57(5):275-83.
27. Stoddart KP, Burke L, King R. Asperger Syndrome in Adulthood: A Comprehensive Guide for Clinicians. New York, NY: WW Norton & Co; 2012.
28. Lai MC, Lombardo MV, Baron-Cohen S. Autism. Lancet. 2014;383(9920): 896-910.
29. Serafini G, Pompili M, Innamorati M, Rihmer Z, Sher L, Girardi P. Can cannabis increase the suicide risk in psychosis? A critical review. Curr Pharm Des. 2012;18(32):5165-87.
30. Brooner RK, King VL, Kidorf M, Schmidt CW Jr., Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry. 1997;54(1):71-80.
31. Wilcox HC, Conner KR, Caine ED. Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies. Drug Alcohol Depend. 2004;76(Suppl):S11-9.
32. Cassidy S, Bradley P, Robinson J, Allison C, McHugh M, Baron-Cohen S. Suicidal ideation and suicide plans or attempts in adults with Asperger’s syndrome attending a specialist diagnostic clinic: a clinical cohort study. Lancet Psychiatry. 2014;1(2):142-7.
33. White TJ. A window into the neurobiology of childhood and adolescent psychopathology. J Am Acad Child Adolesc Psychiatry. 2013;52(1):9-11.
34. Wood JJ, Ehrenreich-May J, Alessandri M, et al. Cognitive behavioral therapy for early adolescents with autism spectrum disorders and clinical anxiety: a randomized, controlled trial. Behav Ther. 2015;46(1):7-19.
35. Palmqvist M, Edman G, Bolte S. Screening for substance use disorders in neurodevelopmental disorders: a clinical routine? Eur Child Adolesc Psychiatry. 2014;23(5):365-8.
36. Mazefsky C, Kao J, Oswald D. Preliminary evidence suggesting caution in the use of psychiatric self-report measures with adolescents with high-functioning autism spectrum disorders. Res Autism Spectr Disord. 2011;5(1):164-74.